You are here

Subscribe

Prostate & Urologic Cancer Center Blog

All
All

DCI Center for Prostate & Urologic Cancers Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Jessica Hyland, Editor-In-Chief.

Clinical Trial Helps National Park Services Volunteer Stay Active

Nestled between the 57-mile Cape Lookout National Seashore lies an isolated barrier island, Portsmouth, a former port town that stretches uninhabited for 13 miles and is accessible only by boat. It’s one of the last few wild frontiers along the North Carolina coast and is preserved by the National...

NIH Awards $2.5 Million For Prostate Cancer Research

A group of researchers led by Andrew Armstrong, MD, MSc, professor of medicine and surgery at Duke Cancer Institute, has recently been awarded $2,500,000 from the National Institutes of Health (NIH) to investigate the connection between hormonal resistance in prostate cancer with metastasis and...

Enzalutamide Significantly Improves Progression-Free Survival in Men with Metastatic Prostate Cancer

A multi-institutional group of clinical researchers, led by Duke Cancer Institute’s Andrew Armstrong, MD, MSc, FACP, published a new report this month in the Journal of Clinical Oncology (JCO) that describes results from the ARCHES study. ARCHES prospectively studied and evaluated the efficacy and...

Study Finds How Prostate Cancer Cells Mimic Bone When They Metastasize

Prostate cancer often becomes lethal as it spreads to the bones, and the process behind this deadly feature could potentially be turned against it as a target for bone-targeting radiation and potential new therapies. In a study published online Tuesday in the journal PLOS ONE , Duke Cancer...

DCI Center for Prostate & Urologic Cancers Present at EAU

Physician-scientists from DCI Center for Prostate & Urologic Cancers recently presented data at the 2019 European Association of Urology (EAU) Congress held in Barcelona, Spain, from March 15 -19. Held annually, over 10,000 colleagues throughout the world gather for the scientific retreat to...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

Adventurer Confronts Daunting Cancer Diagnosis

Ron Deranek, 68, loves the adrenaline a great hike brings to him, and he will travel anywhere in North Carolina to seek out the best mountain-top views. When he committed to hiking the Grandfather Trail at Grandfather Mountain, a 2.4-mile ridgetop stretch to Calloway Peak (better known as the “...

DCI Launches Center for Prostate & Urologic Cancers

Duke Cancer Institute (DCI) officially launched the new DCI Center for Prostate & Urologic Cancers, a center of excellence supporting a growing multi-disciplinary clinical and translational research team. The DCI Center for Prostate & Urologic Cancers will be led by a multi-disciplinary...

New Prostate Cancer Prognostic Model For Enzalutamide

Researchers at the Duke Prostate & Urologic Cancer Center, led by genitourinary oncologist Andrew Armstrong, MD, have recently developed a novel nomogram, a prognostic model that measures overall survival for men with metastatic prostate cancer who were treated with enzalutamide, according to...

The Relationship of the B7H3 Immune Checkpoint to Prostate Cancer Outcomes

Prostate cancer is known to be an immune evasive tumor, often coexisting with areas of inflammation in the primary site, but without over-expression of the traditional PD-1/PD-L1 immune checkpoint, unlike many other cancer subtypes. While certain prostate cancer subsets like microsatellite high (...

Somarelli Awarded Prostate Cancer Research Funding

A team of researchers led by Duke Cancer Institute scientist Jason Somarelli, PhD, has been awarded a Prostate Cancer Research Program (PCRP) Idea Development Award — New Investigator, totaling $350,000, by the United States Department of Defense Office of Congressionally Directed Medical Research...

Sound Waves Could Provide New Tool To Fight Cancer

Sound waves may become the next effective tool to help doctors diagnose cancer and develop more personalized diagnostics and treatments. A new study conducted by researchers from Duke University, MIT and Singapore's Nanyang Technological University shows that sound waves are capable of rapidly and...

Pages